Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.02 HKD
Change Today +0.02 / 1.00%
Volume 6.3M
1011 On Other Exchanges
Symbol
Exchange
Berlin
As of 4:01 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

china nt pharma group co ltd (1011) Snapshot

Open
$2.00
Previous Close
$2.00
Day High
$2.09
Day Low
$1.99
52 Week High
04/9/15 - $2.37
52 Week Low
05/20/14 - $0.79
Market Cap
2.6B
Average Volume 10 Days
9.1M
EPS TTM
$0.0019
Shares Outstanding
1.3B
EX-Date
--
P/E TM
845.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NT PHARMA GROUP CO LTD (1011)

Related News

No related news articles were found.

china nt pharma group co ltd (1011) Related Businessweek News

No Related Businessweek News Found

china nt pharma group co ltd (1011) Details

China NT Pharma Group Company Limited, together with its subsidiaries, operates as a third-party promotional and sales services provider of pharmaceuticals and vaccines in the People’s Republic of China. It operates in three segments: Third-Party Pharmaceutical Promotion and Sales; Proprietary Products Production and Sales; and Third-Party Vaccines and Other Pharmaceuticals. The Third-Party Pharmaceutical Promotion and Sales segment engages in selling and marketing third-party manufactured pharmaceutical products to customers, as well as providing marketing and promotion services. The Proprietary Products Production and Sales segment is involved in the production and sale of NT branded products and generic drugs. The Third-Party Vaccines and Other Pharmaceuticals segment provides supply chain services for pharmaceutical/vaccine products. The company also offers logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Shanghai, the People's Republic of China.

497 Employees
Last Reported Date: 03/19/15
Founded in 1995

china nt pharma group co ltd (1011) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY5.3M
Honorary Advisor
Total Annual Compensation: CNY2.0M
Compensation as of Fiscal Year 2013.

china nt pharma group co ltd (1011) Key Developments

China NT Pharma Group Company Limited Reports Consolidated Earnings Results for the Year Ended December 31, 2014

China NT Pharma Group Company Limited reported consolidated earnings results for the year ended December 31, 2014. For the period, the company reported turnover was RMB 864,621,000 compared with RMB 754,115,000 for the same period last year. Profit from operations was RMB 96,071,000 compared with loss from operations of RMB 577,638,000 for the same period last year. Profit attributable to equity shareholders of the company was RMB 2,087,000 or 0.19 diluted per share compared with RMB 673,458,000 or 62.24 diluted per share for the same period last year. Profit before taxation was RMB 17,327,000 compared with loss before taxation RMB 652,841,000 for the same period last year. The improvement in operating results during the year ended 31 December 2014 was mainly due to significantly lower selling and distribution expenses and administrative expenses; as well as no further incurrence of business restructuring costs. Total revenue for the year ended December 31, 2014 increase was due to the increase in revenue from the third-party pharmaceutical promotion and sales business as well as the proprietary product production and sales business. Total capital expenditure increased by RMB 99.5 million or 559.0% to RMB 117.3 million for the year ended 31 December 2014, as compared to RMB 17.8 million for the year ended 31 December 2013. The capital expenditure was mainly used for constructing the factory building and acquiring the leasehold land for Group's new factory in Taizhou. Net debt was RMB 107,228,000 compared with RMB 135,728,000 for the same period last year. Net cash generated from operating activities was RMB 72,723,000 compared with net cash used in operating activities RMB 38,480,000 for the same period last year.

China NT Pharma Group Company Limited Appoints Chiu Yu Kang as Chief Financial Officer

China NT Pharma Group Company Limited announced that Mr. Chiu Yu Kang has been appointed as the Chief Financial Officer of the company with effect from 2 April 2015. Prior to joining the Company, Mr. Chiu was the vice president, chief financial officer and company secretary of a company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

China NT Pharma Group Company Limited Announces Board Changes

The board of directors of China NT Pharma Group Company Limited announced that Mr. Wu Weizhong has been appointed as an executive Director of the company with effect from March 20, 2015. Mr. Wu has over 18 years of experience in pharmaceutical manufacturing. Mr. Wu has entered into an appointment letter with the company for a term of three years commencing from March 20, 2015. The Board further announced that Mr. Wang Fan has resigned as a non- executive Director of the company with effect from March 20, 2015 due to his other business engagements which require more time for his dedication.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1011:HK $2.02 HKD +0.02

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings 100.0x
Price/Sales 2.0x
Price/Book 8.2x
Price/Cash Flow 1,006.3x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NT PHARMA GROUP CO LTD, please visit www.ntpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.